Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2005
09/09/2005WO2005082073A2 Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (cxcr2) single nucleotide polymorphism
09/09/2005WO2005082043A2 Thermal cycling device
09/09/2005WO2005082020A2 Flavivirus vaccines
09/09/2005WO2005082008A2 Methods for diagnosing and treating bladder cancer
09/09/2005WO2005081867A2 Salivary mrna profiling, biomarkers, and related methods and kits of parts
09/09/2005WO2005081783A2 Method for determination and quantification of radiation or genotoxin exposure
09/09/2005WO2005064012A3 Method for validating and/or calibrating a system for performing hybridisation experiments, microarray, and kit therefor
09/09/2005WO2005064007A3 Means for screening a gtpase activity of controllers
09/09/2005WO2005062947A3 Methods and compositions for identifying rna-binding proteins
09/09/2005WO2005062940A3 Method and apparatus for in vivo collection and surveillance of circulating biological components
09/09/2005WO2005059156A3 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used
09/09/2005WO2005058957A3 Ztnf 12, a tumor necrosis factor
09/09/2005WO2005056818A8 Electrochemical assay for the identification of microorganisms
09/09/2005WO2005054866A3 Diagnostics and therapeutics for diseases associated with two-pore domain potassium channel (kcnk2)
09/09/2005WO2005054515A3 Novel method for isolating single stranded product
09/09/2005WO2005054461A3 Transcriptional regulators and methods thereof
09/09/2005WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds
09/09/2005WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins
09/09/2005WO2005045059A3 Allele assignment and probe selection in multiplexed assays of polymorphic targets
09/09/2005WO2005042760A3 Systems and methods for detecting biological features
09/09/2005WO2005040985A3 Methods for calibrating mass spectrometry (ms) and other instrument systems and for processing ms and other data
09/09/2005WO2005040795A3 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepli)
09/09/2005WO2005039635A3 Genes involved in neurodegenerative disorders
09/09/2005WO2005038596A3 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion
09/09/2005WO2005036169A3 Fluorescent probes for ribosomes and method of use
09/09/2005WO2005035794A3 Detection of prrsv
09/09/2005WO2005030802A3 Antigens for an east coast fever vaccine
09/09/2005WO2005028678A3 Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
09/09/2005WO2005024045A3 Primers for use in detecting beta-lactamases
09/09/2005WO2005017203A3 Systems and methods for diagnosing and treating psychological and behavioral conditions
09/09/2005WO2005005668A3 Diagnosis and treatment methods related to aging (8a)
09/09/2005WO2004112763A3 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
09/09/2005WO2004085608A3 Methods for high throughput elucidation of transcriptional profiles and genome annotation
09/09/2005WO2004080146A3 A marker system for characterizing undifferentiated human embryonic stem cells
09/09/2005WO2004076628A3 Overexpression, purification and characterization of a thermolabile phosphatase
09/09/2005WO2004074976A8 Reording medium, playback device, recording method, playback method, and computer program
09/09/2005WO2004050835A8 Predicting animal performance
09/09/2005WO2004044556A3 Diagnosis of sepsis or sirs using biomarker profiles
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005WO2001018253A9 Gene manipulation method using homologous recombination
09/09/2005CA2564612A1 Method, chip, device and system for collection of biological particles
09/09/2005CA2558758A1 Botulinum toxin screening assays
09/09/2005CA2558666A1 Salivary mrna profiling, biomarkers, and related methods and kits of parts
09/09/2005CA2558604A1 Diagnosis of (a risk of) disease and monitoring of therapy
09/09/2005CA2558499A1 Method for the identification of sepsis
09/09/2005CA2558256A1 Oligonucleotides related to lipid membrane attachments
09/09/2005CA2558187A1 Method for covalently immobilising biomolecules on organic surfaces
09/09/2005CA2557841A1 Polony fluorescent in situ sequencing beads
09/09/2005CA2557729A1 Reduction of spontaneous mutation rates in cells
09/09/2005CA2557543A1 Method for detecting a microorganism in a fecal specimen
09/09/2005CA2557519A1 Detection of human papillomavirus
09/09/2005CA2557503A1 Methods for diagnosing and treating bladder cancer
09/09/2005CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
09/09/2005CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005CA2557487A1 Detection of contaminants retained on a filter by a detectable moiety-producing substrate
09/09/2005CA2557486A1 Method, chip, device and system for extraction of biological materials
09/09/2005CA2557485A1 Method, chip, device and integrated system for detection biological particles
09/09/2005CA2557481A1 Culture methods for cryptosporidium
09/09/2005CA2557438A1 Identification of cancer protein biomarkers using proteomic techniques
09/09/2005CA2557181A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
09/09/2005CA2557136A1 Flavivirus vaccines
09/09/2005CA2557093A1 Cancerous disease modifying antibodies
09/09/2005CA2557091A1 Cancerous disease modifying antibodies
09/09/2005CA2556925A1 Surrogate markers of neuropathic pain
09/09/2005CA2556890A1 Breast cancer prognostics
09/09/2005CA2556834A1 Reagents, kits and methods for immunodetection of epitopes on molecules
09/09/2005CA2556022A1 Protein phosphorylation in t-cell receptor signaling pathways
09/09/2005CA2556021A1 Protein phosphorylation in anaplastic large cell lymphoma
09/09/2005CA2556019A1 Protein phosphorylation in c-src signaling pathways
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005CA2555259A1 Genetic polymorphisms associated with stroke, methods of detection and uses thereof
09/09/2005CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/08/2005US20050198695 Nematode ATP synthase subunit E-like sequences
09/08/2005US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease
09/08/2005US20050197783 Methods and systems for extension, exploration, refinement, and analysis of biological networks
09/08/2005US20050197554 Composite thin-film glucose sensor
09/08/2005US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/08/2005US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease
09/08/2005US20050197309 Antisense modulation of dual specific phosphatase 5 expression
09/08/2005US20050197307 Antagonizing interaction between polynucleotide sequence 1 and interferon regulatory factor 1 (IRF 1); herpes virus infections
09/08/2005US20050197305 Methods and compositions for blocking progression of a disease state
09/08/2005US20050197295 Modified annexin proteins and methods for preventing thrombosis
09/08/2005US20050196877 Stress-based electrostatic monitoring of chemical reactions and binding
09/08/2005US20050196860 Novel EPS8 compounds for therapy and diagnosis and methods for using same
09/08/2005US20050196858 Isolation, selection and propagation of animal transgenic stem cells
09/08/2005US20050196856 Polyelectrolyte-coated size-exclusion ion-exchange particles
09/08/2005US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods
09/08/2005US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders
09/08/2005US20050196825 Nutrient broth comprising beta -D-glucuronide, a alpha -D-galactoside chromogenic substrate and beta -D-galactoside for use in detection, quantification or differentiation of general coliforms
09/08/2005US20050196822 Anthrax lethal factor is a mapk kinase protease
09/08/2005US20050196820 Combining dry reagent electrochemical enzyme based biosensors with apoenzyme reactivation technology to produce a novel combination dry reagent test platform technology capable of detecting a wide range of different analytes, for detecting an antigen in a liquid sample
09/08/2005US20050196807 Gene mining system and method
09/08/2005US20050196806 Prostate specific antigen oligoepitope peptide
09/08/2005US20050196805 Oligonucleotide primers for use as diagnostic tool in detection of plant bacterial pathogen of plants
09/08/2005US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening
09/08/2005US20050196801 Screening assays for agonists or antagonists or receptor activator of NF-kappaB
1 ... 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 ... 3003